LATEST MANUSCRIPTS IN Clinical and Molecular Hepatology
Vy H Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H Nguyen. Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study.Clinical and molecular hepatology. 2023, 29 (4): 1002-1012
Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim. Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis.Clinical and molecular hepatology. 2023, 29 (4): 1013-1028
Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon. Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection.Clinical and molecular hepatology. 2023, 29 (4): 1029-1042
Daphne J Theodorou, Stavroula J Theodorou, Ioannis V Mitselos. Letter regarding "Evidence-based hyponatremia management in liver disease".Clinical and molecular hepatology. 2023, 29 (4): 1043-1045
Ji Young Ryu, Seon Ha Baek, Sejoong Kim. Correspondence on Letter regarding "Evidence-based hyponatremia management in liver disease".Clinical and molecular hepatology. 2023, 29 (4): 1048-1049
Eileen L Yoon, Dae Won Jun. Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease".Clinical and molecular hepatology. 2023, 29 (4): 1050-1051
Gi-Ae Kim, Joon Ho Moon, Won Kim. Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity.Clinical and molecular hepatology. 2023, 29 (4): 831-843
Eileen L Yoon, Dae Won Jun. Waiting for the changes after the adoption of steatotic liver disease.Clinical and molecular hepatology. 2023, 29 (4): 844-850
Landon L Chan, Stephen L Chan. The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment.Clinical and molecular hepatology. 2023, 29 (4): 909-923
Ji Young Ryu, Seon Ha Baek, Sejoong Kim. Evidence-based hyponatremia management in liver disease.Clinical and molecular hepatology. 2023, 29 (4): 924-944
Hwa Kyung Byun, Changhwan Kim, Jinsil Seong. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma.Clinical and molecular hepatology. 2023, 29 (4): 945-957
Sung Uk Lee, Tae Hyun Kim. Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma.Clinical and molecular hepatology. 2023, 29 (4): 958-968